Trial of Pregabalin, Alprazolam, and Placebo in Subjects With Anxiety Prior to Dental Procedure
Status:
Completed
Trial end date:
2006-10-01
Target enrollment:
Participant gender:
Summary
The primary purpose of the trial is to assess how effective pregabalin, alprazolam, and
placebo are at reducing anxiety levels of subjects who take a dose of these treatments 4
hours before a scheduled dental procedure.
Phase:
Phase 2
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.